Use Symbicort
Found 6 free book(s)
QUICK GUIDE TO USING YOUR SYMBICORT INHALER
www.symbicorttouchpoints.comSYMBICORT (two puffs), rinse your mouth with water. Spit out the water. Do not swallow it. REMEMBER Use SYMBICORT twice a day, morning and evening. While taking SYMBICORT, never use another medicine that contains a LABA. SYMBICORT is not, and will not replace, a rescue inhaler for sudden symptoms.
AsthmA & COPD meDiCAtiOns ALLERGIC RHINITIS …
d8z57tiamduo7.cloudfront.netSymbicort Turbuhaler a budesonide/formoterol 100/6 • 200/6 • 400/12 c DuoResp Spiromax a budesonide/formoterol c all units in mcg Symbicort Rapihaler a budesonide/formoterol 50/3 •100/3 • 200/6 c Flutiform Inhaler a fluticasone propionate/formoterol 50/5 • 125/5 • 250/10 Breo Ellipta a fluticasone furoate/vilanterol 100/25 c 2.5/2 ...
How to Use Your Symbicort Inhaler(budesonide/formoterol)
www.med.umich.edu1. Remove Symbicort cap. Place middle or index finger on top of canister and thumb underneath the mouthpiece of the inhaler. 2. Shake inhaler for 5-10 seconds.
Therapeutic Class Overview Inhaled Corticosteroid and Long ...
www.medicaid.nv.govMar 22, 2012 · (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology. 2006;11:276-86. 16. Eid NS, Noonan MJ, Chipps B, Parasuraman B, Miller CJ, O’Brien CD. Once- vs twice-daily budesonide/formoterol in 6- to 15-year old patients with stable asthma.
Therapeutic Drug Substitution
www.utoledo.eduSymbicort 160mcg/4.5mcg Advair HFA 230mcg/21mcg Dulera 100mcg/5mcg Substituted To Advair HFA 115mcg/21mcg Dulera 200mcg/ 5mcg Advair HFA 230mcg/21mcg Breo Ellipta 100/25 1 inhalation daily Substituted to Advair HFA 230mcg/21mcg . Policy 3364-133-36 Therapeutic Drug Substitutions Page 9 ...
SYMBICORT Prescribing Information
den8dhaj6zs0e.cloudfront.net5.3 Excessive Use of SYMBICORT and Use with Other Long-Acting Beta. 2-Agonists 5.4 Local Effects 5.5 Pneumonia and Other Lower Respiratory Tract 7.1 Inhibitors of Cytochrome P4503A4 Infections 7.2 Monoamine Oxidase Inhibitors and Tricyclic 5.6 Immunosuppression 5.7 Transferring Patients From Systemic Corticosteroid Therapy